tiprankstipranks
Advertisement
Advertisement
HIMS Stock Rallies after Canaccord Raises Price Target to Street-High of $40
PremiumMarket NewsHIMS Stock Rallies after Canaccord Raises Price Target to Street-High of $40
10d ago
Hims & Hers price target raised to $36 from $25 at BofA
Premium
The Fly
Hims & Hers price target raised to $36 from $25 at BofA
10d ago
Hims & Hers price target raised to $40 from $32 at Canaccord
Premium
The Fly
Hims & Hers price target raised to $40 from $32 at Canaccord
10d ago
Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%
PremiumThe FlyCboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%
23d ago
Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth
Premium
Market News
Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth
23d ago
Hims & Hers price target raised to $39 from $29 at Barclays
Premium
The Fly
Hims & Hers price target raised to $39 from $29 at Barclays
24d ago
Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%
PremiumThe FlyCboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%
1M ago
Hims & Hers appoints Anant Vinjamoori as CMO, Hims
Premium
The Fly
Hims & Hers appoints Anant Vinjamoori as CMO, Hims
1M ago
Hims & Hers Reaffirmed at Buy as Analyst Sees Peptide Upside, Keeps $32 Price Target Unchanged
Premium
Ratings
Hims & Hers Reaffirmed at Buy as Analyst Sees Peptide Upside, Keeps $32 Price Target Unchanged
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100